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pnlike myxomatous mitral regurgitation (MR), the
management of chronic ischemic mitral regurgitation
IMR) remains a contentious issue. Numerous questions
bound. Is revascularization enough? When should repair
e undertaken? Should a partial or complete ring be used?
hould the annulus be downsized? Is outright valve re-
lacement ever indicated and, if so, what type of valve
hould be used? With the rise in percutaneous interven-
ions, straightforward coronary revascularizations are be-
oming less frequent. Without question, we are operating
n patients with more advanced coronary artery disease
ith frequently associated ventricular dysfunction. As our
atients become older and less healthy, we will be re-
uired to deal with chronic IMR more frequently. In this
rticle, we present the rationale we use when we consider
ow to best manage these patients, and will outline the
reoperative and operative approach that we undertake
hen dealing with chronic IMR.
A thorough understanding of the underlying pathophysi-
logy of IMR is necessary. The function of the normal mitral
alve results from a complex interplay among the annulus,
alvular, and subvalvular elements. In his classification
cheme, Carpentier delineates chronic IMR as type IIIb1 (Fig.
). IMR results when posterolateral scar leads to a tethered
osteromedial papillary muscle.
IMR has been shown to predict a poor prognosis.2-5
istorically, the treatment of IMR has been conservative,
aking the philosophy that MR may improve with revascu-
arization alone.6,7 New evidence has been presented indi-
ating that even more moderate amounts of MR in patients
ndergoing coronary artery bypass do not resolve after
oronary bypass alone8,9 and may actually lead to a reduc-
ion in long-term survival.6 Some authors have also indi-
ated that adding a mitral valve repair to this group of
atients with 2 to 3 MR will improve late survival.10
owever, the reports of adding mitral valve surgery to
oronary artery bypass to improve survival and late func-
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oi:10.1053/j.optechstcvs.2005.05.003ional class are controversial, because other reports have
ailed to show any benefit.11,12 In none of these papers was
urvival lower than for those patients undergoing coro-
ary artery bypass alone, and previously referenced cited
apers2-5 indicate that untreated MR would lead to a de-
reased survival. All of these studies, however, suffer from
he common critique that they include a relatively small
ample size and have limitations of retrospective studies
although attempts are made to account for this with pro-
ensity matching and multivariable analysis).
An increasing number of our patients have more ad-
anced coronary disease and worse ventricular function.
e believe that in such patients significant IMR is unlikely
o improve with revascularization alone, and that a con-
ervative approach is outdated. An aggressive approach
hould be taken when treating IMR and in preventing its
ecurrence.
The largest series in the literature to examine recurrent
schemic MR comes from the Cleveland Clinic Foundation
nd includes 585 patients who underwent annuloplasty per-
ormed over a 17-year period.13 Nearly one third of patients
ad return of 3 to 4 MR at 1 year.
Three concepts explain the recurrence of IMR. First,
here has been a long held dogma that the intertrigonal
istance is fixed. Recent work from several investigators
as shown that the intertrigonal distance is subject to di-
ation.14-16 Second, Miller’s laboratory has shown that fix-
tion of the septal-lateral dimension, or distance from the
nterior annulus to the posterior annulus, is important in
reventing return of MR after repair. Third, the annulus
symmetrically dilates at the medial commissure, or P3
egion. Although partial rings can provide good immedi-
te repair of IMR, they provide protection from dilation of
either the intertrigonal nor septal-lateral dimension. In
ddition, standard complete rings do not address the
symmetric dilation found in ischemic MR.
Our belief that type IIIb MR would be best treated by a
omplete remodeling ring that provides additional reduction
o the tethered P3 region led to the development of the Car-
entier-McCarthy-Adams IMR ETlogix annuloplasty ring
Edwards Lifesciences, Irvine, CA).
Is there ever a role for outright valve replacement in ischemic
R? Calafiore and coworkers have shown that mitral valve co-
ptation depth, or the distance between themitral valve annular
lane and the coaptation point of the mitral leaflets, is a strong
redictor of recurrent MR.17 An increased coaptation depth is
ssociated with a more spherical ventricle, and in their series,
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102 E.C. McGee and P.M. McCarthyalafiore reported that values greater than 10 mm were at high
isk of recurrent MR after repair with a nonring suture annulo-
lasty. In the Cleveland Clinic series that looked at repair versus
eplacement for IMR, repair was associated with improved sur-
Figure 1 Carpentier classification of mitral regurgitation
Restricted leaflet motion. (A) Diastolic and systolic re
available online at http://www.us.elsevierhealth.com/opival except in the least healthy subset of patients.18,19 In severely mompromised individuals with extensive leaflet tethering, we
trongly consider proceeding directly to chordal sparing mitral
alve replacement using a bioprosthetic valve.Webelieve that in
atients with limited long-term survival, there is no place for a
rmal leaflet motion. (II) Increased leaflet motion. (III)
n. (B) Systolic restriction. (Color version of figure is
vs/.). (I) No
strictioechanical prosthesis.
Correction of ischemic mitral regurgitation 103Operative Approach
Figure 2 Intraoperative transesophageal echocardiography (TEE) is performed as conduits are being harvested. The
anatomy of the valve and subvalvular apparatus is carefully assessed, and the mechanism of the MR is confirmed. A
“normal” valvular and subvalvular apparatus characterizes ischemic MR. Most commonly, a central or posterior jet is
noted, but careful study of the jet will reveal a larger jet arising from the P2/P3 region and a smaller jet comes from the
anterolateral commissure. Our practice has evolved to the routine repair of 2 or greater MR. If lesser degrees of MR
are noted, we will pharmacologically increase the blood pressure to a mean of 90 to 100 mm Hg and then reassess the
MR. If the MR increases to 2 or greater, we repair the mitral valve. Most patients require concomitant coronary artery
revascularization and mitral valve repair. A full median sternotomy is used. Standard aortic and bicaval cannulation is
performed. We have found that vacuum-assisted venous drainage allows us to use smaller venous cannulae and still
have a bloodless field. Normothermic bypass is established, and the heart is arrested with a combination of antegrade
and retrograde cold blood–modified Buckberg cardioplegia (4°C). Distal vein or radial artery anastomoses are com-
pleted and then connected to the cardioplegia manifold. Cardioplegia is administered retrograde and down grafts at
least every 15 minutes to maintain myocardial protection. Caval isolation is achieved, and a standard left atriotomy is
performed after developing the interatrial groove. The atriotomy is extended under the superior vena cava and inferior
vena cava. Placing traction on the caval tourniquets, which are subsequently attached to the operative drape, can
facilitate additional exposure. Left-side pericardial well sutures are removed.We use a self-retaining mitral retractor for
all cases. The table is rotated away from the surgeon. If the view is still inadequate, a sponge on a ring forceps can be
placed on top of the heart to depress the medial commissure. A small, metal-tip basket suction is placed in the left
superior pulmonary vein to scavenge blood returning through the pulmonary bed. (Color version of figure is available
online at http://www.us.elsevierhealth.com/optechstcvs/.)
104 E.C. McGee and P.M. McCarthyFigure 3 Although intraoperative TEE is always performed, direct inspection of the mitral valve is necessary to confirm
pathology. Cold saline solution is infused into the ventricle under pressure to demonstrate the leak. The valve and the
subvavular apparatus are carefully studied. With type IIIb ischemic MR, typically the posteromedial papillary muscle
is tethered and the annulus is asymmetrically deformed at the P3 region. Findings may be subtle depending on the
amount of tethering present. (Color version of figure is available online at http://www.us.elsevierhealth.com/optech-
stcvs/.)
Correction of ischemic mitral regurgitation 105Figure 4 We generally start placing nonpledgeted sutures of 2-0 braided suture in the middle of the posterior annulus.
Traction on these sutures sets up exposure of the entire valve. Generally, 8 sutures are placed in the posterior annulus
and 6 sutures are placed in the anterior annulus. We size the ring to the surface area of the anterior leaflet. Unlike
myxomatous disease, the leaflets are not elongated. (Color version of figure is available online at http://www.
us.elsevierhealth.com/optechstcvs/.)
106 E.C. McGee and P.M. McCarthyFigure 5 The 26-mm or 28-mm Carpentier-McCarthy-Adams IMR ETLogix ring is typically used. Sutures are passed
through the ring with appropriate spacing, and then the ring is lowered into the annulus after moistening the sutures
with saline solution. The ring is sized to the anterior leaflet. (Color version of figure is available online at http://
www.us.elsevierhealth.com/optechstcvs/.)
Correction of ischemic mitral regurgitation 107Figure 6 We usually tie the sutures along the anterior annulus first and tie the sutures over P3 last to allow for as much
remodeling as possible. The left atrial appendage is excluded with an over and over or purse string stitch of 4-0
polypropolene. (Color version of figure is available online at http://www.us.elsevierhealth.com/optechstcvs/.)
108 E.C. McGee and P.M. McCarthyFigure 7 The ventricle is pressurized with cold saline solution to test for a residual leak. Occasionally, an edge-to-edge
repair with 4-0 braided suture may be required if a residual leak is noted, usually at the medial commissure. (Color
version of figure is available online at http://www.us.elsevierhealth.com/optechstcvs/.)
Figure 8 De-airing maneuvers are performed as the atrium is closed. The left internal mammary artery to left anterior
descending coronary artery anastomosis is constructed, and proximal anastomoses are fashioned (Fig 8). Further
de-airing maneuvers are performed. The cross clamp is released with flow diminished and the aortic vent on suction.
If indicated, left ventricular reconstruction (modified Dor procedure) and tricuspid repair are performed while the
heart reperfuses. After weaning from bypass, TEE is used to assess the adequacy of repair. MR greater that 1 is not
accepted and is dealt with by additional repair or choral sparing mitral valve replacement. (Color version of figure is
available online at http://www.us.elsevierhealth.com/optechstcvs/.)
Correction of ischemic mitral regurgitation 109Figure 9 For mitral valve replacement, the exposure and setup are the same as for mitral valve repair. The anterior leaflet
usually is split at its midpoint. The midportion of the anterior leaflet can be removed if it is bulky, but this is rare in
ischemic MR. (Color version of figure is available online at http://www.us.elsevierhealth.com/optechstcvs/.)
Figure 10 Pledgetted 2-0 braided sutures are placed with the pledgets on the atrial side. Sutures are placed so as to
incorporate annulus and the leaflet, and act to plicate the chords to the annulus. (Color version of figure is available
online at http://www.us.elsevierhealth.com/optechstcvs/.)
110 E.C. McGee and P.M. McCarthyFigure 11 A dental mirror is useful to determine the midpoint of the left ventricular outflow tract. The landmark for this
is the left and noncoronary commissural post of the aortic valve. The struts of the bioprosthesis are oriented so that they
straddle the outflow tract and do not impinge on it. This is accomplished by passing the sutures that lie in the middle
of the left ventricular outflow tract between the struts on the valve. (Color version of figure is available online at
http://www.us.elsevierhealth.com/optechstcvs/.)
Correction of ischemic mitral regurgitation 111Figure 12 The bioprosthetic valve (bovine Carpentier-Edwards PERIMOUNT pericardial bioprosthesis [Edwards
Lifesciences, Irvine, CA]) is carefully seated. Sutures are tied first at each of the struts, and then over the
circumference of the valve. The holder is not removed until all sutures are tied. The atrium is closed and de-aired
in the standard fashion. We avoid lifting the heart if a valve has been placed, especially in frail elderly patients.
(Color version of figure is available online at http://www.us.elsevierhealth.com/optechstcvs/.)
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112 E.C. McGee and P.M. McCarthyonclusion
MR is a serious problem. It is often associated with advanced
oronary artery disease anddiminished left ventricular function.
e believe it warrants an aggressive treatment philosophy. It is
mportant to completely eliminate MR in the operating room
nd to take measures to limit its recurrence. We feel that IMR is
rimarily a ventricular problem and is best dealt with by using a
omplete annuloplasty ring that fixes both the intertrigonal and
eptal-lateral dimension, and remodels the tethered P3 region.
n those individualswith severeMRand a severely depressed left
entricle, a chordal sparingmitral valve replacement with a bio-
rosthetic valve is a reasonable alternative.
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